Author:
Lal Dave R.,Davidoff Andrew M.
Publisher
Springer International Publishing
Reference79 articles.
1. Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18(6):719–31.
2. Yan P, Qi F, Bian L, Xu Y, Zhou J, Hu J, et al. Comparison of incidence and outcomes of neuroblastoma in children, adolescents, and adults in the United States: a Surveillance, Epidemiology, and End Results (SEER) Program Population Study. Med Sci Monit Int Med J Exp Clin Res. 2020;26:e927218.
3. Georgakis MK, Dessypris N, Baka M, Moschovi M, Papadakis V, Polychronopoulou S, et al. Neuroblastoma among children in Southern and Eastern European cancer registries: variations in incidence and temporal trends compared to US. Int J Cancer. 2018;142(10):1977–85.
4. van Heerden J, Kruger M. Management of neuroblastoma in limited-resource settings. World J Clin Oncol. 2020;11(8):629–43. https://doi.org/10.5306/wjco.v11.i8.629. PMID: 32879849; PMCID: PMC7443833.
5. Stiller CA, Parkin DM. International variations in the incidence of neuroblastoma. Int J Cancer. 1992;52(4):538–43.